基金产品介绍与分析系列六十二：中证医疗指数全年表现优异，估值黄金坑点位静待修复

要点 1 2020 1.1 2020 1.2 1.2.1 1.2.2 CXO 1.3 1.3.1 1.3.2 1.3.3 2.2 3 3.1 12020 ............................................................................................................... 5 22020 ...................................................................................................................... 6 32020 ...................................................................................................................................... 7 42020 ...................................................................................................................................... 7 52016~2019 ..................................................................................... 8 620M1-9Biotech .................................................................................................... 8 72014-2022E ...................................................................................................... 10 82018 ......................................................................................... 10 9 .................................................................................................................. 10 102019300 ........................................................................................... 10 11201980% ........................................................................................................... 11 12 ................................................................................................................ 11 13 .................................................................................................................................... 11 14IVD2013-2019 .............................................................................................. 12 15IVD2013-2019 .............................................................................................. 12 162015-2024E ................................................................................ 13 172015-2024E ........................................................................ 13 18 ........................................................................................................................ 14 19 ........................................................................................................ 16 20 .................................................................................................................................... 16 21 ............................................................................................................ 17 22ETF ................................................................................................................... 17 23 ........................................................................................ 19 24 ........................................................................................................ 20 25 ........................................................................................................................ 21 26PE ................................................................................................. 22 27PB ................................................................................................. 22 28 ................................................................................ 23 29 ........................................................................................ 24 30 ........................................................................................ 24 31 ........................................................................................ 24 32 ........................................................................................ 24 12020 .................................................................................................................. 6 22018 ................................................................................................................... 6 36000 ........................................................................................................................................ 11 4ETF ..................................................................................................................................... 15 5 .................................................................................................................. 15 6ETF ..................................................................................... 16 7 .............................................................................................................................................. 17 8 ...................................................................................................... 18 9 ..............................................................................................................................